Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FOXG1 antisense RNA 1 (FOXG1-AS1) is a long non-coding RNA (lncRNA) transcribed from the genomic region antisense to the FOXG1 gene (forkhead box G1) on human chromosome 14q12[3][9]. Like other lncRNAs, FOXG1-AS1 does not encode protein and is thought to act primarily as a regulatory RNA, potentially modulating the expression of the FOXG1 gene through antisense or epigenetic mechanisms. The FOXG1-AS1 locus is annotated in multiple genome databases and is also known as LINC01551[3][9]. While FOXG1 itself is critical for neurodevelopment and acts as a transcription factor with key roles in the formation and function of the cerebral cortex, the precise biological role and mechanism of FOXG1-AS1 remain incompletely defined. There is currently no direct evidence identifying FOXG1-AS1 as a therapeutic target, and no drugs or biomarkers associated with this lncRNA. Its relevance may derive from influencing FOXG1 expression in neurodevelopmental contexts, but it is not itself a canonical drug target in clinical or preclinical therapy development[3][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FOXG1 antisense RNA 1 (FOXG1-AS1).